←
Loading live data…
PRICE
Loading…
REVENUE MIX
Total Revenue100%
COST
COGS18%
R&D + SG&A40%
Op Margin42%
FINANCIAL HEALTH
REVENUE
$67.6B
Growth
43%
Gross M.
82%
P/E
16.1
EV/EBITDA
0
Net M.
31%
FCF M.
0%
D/E
9.3
Op M.
42%
PLUG INTO YOUR DCF
Historical growth
17.3%
Analyst 5y growth
—
Forward P/E
13.8
PEG ratio
1.50
Trailing EPS
$63.60
Forward EPS
$74.00
🚩 RED FLAG SCANNER — 10-K RISK FACTORS, YEAR OVER YEAR
TAM
SIZE
—
CAGR
—
Market-size estimates aren't available for this stock right now — see Financial Health and Risk Assessment below for a fundamentals-based read instead.
RISK ASSESSMENT
LOWA mechanical base-case DCF (default assumptions) implies 450% upside to $5621.68 — take this as a rough, unverified estimate, not a target.
HIGDebt/equity of 9.30 — elevated leverage, sensitive to rate/refinancing risk.
MEDRevenue growing 43% YoY — the multiple depends on this pace continuing; deceleration is a real risk.
🐂 BULL
GS shows revenue grew +42.5% YoY, 42% operating margin, 17% ROE — a business converting growth into real profit.
🐻 BEAR
At a P/E of 16.1, the stock is priced for continued execution — any deceleration in growth or margin compression would likely pressure the multiple.
AI-powered data, computed by TreasureX · May contain inaccuracies
⚠️
All values, scores, and figures here are computed from your own assumptions and public data, for educational purposes only. This is not investment advice — TreasureX does not recommend buying or selling any security. Results change with your inputs. Please do your own research and use your own judgement before making any investment decision.